Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 13, 2013 - Issue 1
Submit an article Journal homepage
449
Views
39
CrossRef citations to date
0
Altmetric
Research Report

Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey

William D Willis Strategic Affairs Department, LifeScan UK Ltd., Johnson & Johnson, High Wycombe, UK. [email protected]
,
Jesús I Diago-Cabezudo Medical Affairs Department, LifeScan, Johnson & Johnson S.A., Madrid, Spain
,
Anne Madec-Hily Insights Department, LifeScan UK Ltd., Johnson & Johnson, High Wycombe, UK
&
Aftab Aslam Insights Department, LifeScan UK Ltd., Johnson & Johnson, High Wycombe, UK
Pages 123-130 | Published online: 09 Jan 2014

References

  • Holt P. Taking hypoglycaemia seriously: diabetes, dementia and heart disease. Br. J. Community Nurs. 16(5), 246–249 (2011).
  • Bonds DE, Kurashige EM, Bergenstal R et al.; ACCORD Study Group. Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am. J. Cardiol. 99(12A), 80i–89i (2007).
  • Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 28(5), 1245–1249 (2005).
  • Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 26(6), 1902–1912 (2003).
  • Phillippe HM, Wargo KA. Mitiglinide: a novel agent for the treatment of Type 2 diabetes mellitus. Ann. Pharmacother. 44(10), 1615–1623 (2010).
  • Vlckova V, Cornelius V, Kasliwal R, Wilton L, Shakir SA. Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide. Drug Saf. 32(5), 409–418 (2009).
  • Hemmingsen B, Lund SS, Gluud C et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for Type 2 diabetes mellitus. Cochrane Database Syst. Rev. 6, CD008143 (2011).
  • MacLeod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet. Med. 10(3), 238–245 (1993).
  • Curkendall SM, Natoli JL, Alexander CM, Nathanson BH, Haidar T, Dubois RW. Inpatient diabetic hypoglycemia: economic and clinical impact. Endocr. Pract. 1–48 (2009).
  • Curkendall SM, Natoli JL, Alexander CM, Nathanson BH, Haidar T, Dubois RW. Economic and clinical impact of inpatient diabetic hypoglycemia. Endocr. Pract. 15(4), 302–312 (2009).
  • Brito-Sanfiel M, Diago-Cabezudo J, Calderon A. Economic impact of hypoglycemia on healthcare in Spain. Expert Rev. Pharmacoecon. Outcomes Res. 10(6), 649–660 (2010).
  • Hammer M, Lammert M, Mejías SM, Kern W, Frier BM. Costs of managing severe hypoglycaemia in three European countries. J. Med. Econ. 12(4), 281–290 (2009).
  • Lammert M, Hammer M, Frier BM. Management of severe hypoglycaemia: cultural similarities, differences and resource consumption in three European countries. J. Med. Econ. 12(4), 269–280 (2009).
  • Allicar MP, Mégas F, Houzard S, Baroux A, Le Thai F, Augendre-Ferrante B. Frequency and costs of hospital stays for hypoglycemia in France in 1995. Presse Med. 29(12), 657–661 (2000).
  • Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycaemia in Type 2 diabetes. Diabet. Med. 25(3), 245–254 (2008).
  • Leiter LA, Yale JF, Chiasson JL, Harris S, Kleinstiver P, Sauriol L. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can. J. Diabetes 29(3), 186–192 (2005).
  • Currie CJ, Morgan CL, Poole CD, Sharplin P, Lammert M, McEwan P. Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Curr. Med. Res. Opin. 22(8), 1523–1534 (2006).
  • Ritholz MD, Jacobson AM. Living with hypoglycemia. J. Gen. Intern. Med. 13(12), 799–804 (1998).
  • Davis S, Alonso MD. Hypoglycemia as a barrier to glycemic control. J. Diabetes Complicat. 18(1), 60–68 (2004).
  • Diago-Cabezudo JI, Madec-Hily A, Aslam A. Perceptions of hypoglycemia and self-monitoring of blood glucose in insulin-treated diabetes patients: results from a European online survey. Diabetes Manage. 3(1), 15–23 (2013).
  • Kuenen JC, Borg R, Kuik DJ et al.; ADAG Study Group. Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in Type 1 and Type 2 diabetic patients? Diabetes Care 34(8), 1843–1847 (2011).
  • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329(14), 977–986 (1993).
  • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352(9131), 837–853 (1998).
  • Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with Type 2 diabetes. N. Engl. J. Med. 348(5), 383–393 (2003).
  • Giorda CB, Manicardi V, Diago Cabezudo J. The impact of diabetes mellitus on healthcare costs in Italy. Expert Rev. Pharmacoecon. Outcomes Res. 11(6), 709–719 (2011).
  • UK Hypoglycaemia Study Group.Risk of hypoglycaemia in Types 1 and 2 diabetes: effectsof treatment modalities and their duration. Diabetologia 50, 1140–1147 (2007).
  • Harris CR. Feelings of dread and intertemporal choice. J. Behav. Dec. Making 25(1), 13–28 (2012).
  • Frederick S, Loewenstein G, O’Donoghue T. Time discounting and time preference: a critical review. J. Econ. Lit. 40(2), 351–401 (2002).
  • Standards of medical care in diabetes 2012. Diabetes Care 35(Suppl. 1), S11–63 (2012).
  • Hermansen K, Dornhorst A, Sreenan S. Observational, open-label study of Type 1 and Type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study. Curr. Med. Res. Opin. 25(11), 2601–2608 (2009).
  • Kerlan V, Verges B, Tawil C, Lahrichi N, Doucet J. Insulin initiation in elderly patients with Type 2 diabetes in France: a subpopulation of the LIGHT study. Curr. Med. Res. Opin. 28, 503–511 (2012).
  • Standards of medical care in diabetes 2008. Diabetes Care 31(Suppl. 1), S12–54 (2008).
  • Monnier L, Colette C, Lapinski H, Boniface H. Self-monitoring of blood glucose in diabetic patients: from the least common denominator to the greatest common multiple. Diabetes Metab. 30(2), 113–119 (2004).
  • Standards of medical care in diabetes 2011. Diabetes Care 34(Suppl. 1), S11–61 (2011).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.